News
Daily updates on neurointerventional devices, trials, guidelines and meetings.
- Meeting
ESMINT–SNIS joint webinar on dural sinus stenting and its emerging indications, Nov 23
Held online on Monday, Nov 23, 5–6 PM CET (1–2 AM JST on Nov 24).
Source:ESMINT - Meeting
42nd JSNET Annual Meeting (JSNET2026) to be held in Tokyo, Nov 19–21
Presided over by Prof. Yuichi Murayama (Jikei University) under the theme "INNOVATION", at the Grand Prince Hotel Shin Takanawa, Tokyo.
Source:JSNET2026 official website - Dissection
EVT for isolated cervical ICA occlusion due to dissection: no 90-day functional benefit in ETIICA secondary analysis
Of 998 patients, 108 had dissection and 60 underwent EVT. There was no difference in 90-day mRS shift versus best medical treatment (acOR 0.80, 95% CI 0.29–2.20); carotid patency was achieved in 75%, but intracranial embolization occurred in 30%.
Source:Eur Radiol (via PubMed) - Device
Medtronic launches Aristotle Mini guidewire in the US for small distal vessels, including MMA embolization
The guidewire received FDA 510(k) clearance in August 2026. It is compatible with 0.013-inch inner diameter microcatheters and is intended for access to small distal vessels in procedures such as middle meningeal artery embolization, expanding Medtronic's chronic subdural hematoma portfolio after Onyx.
Source:Endovascular Today - Other
FDA approves factor XIa inhibitor asundexian (Sunharbo) for secondary stroke prevention
Approved on Nov 9 as a 50 mg tablet used with antiplatelet therapy after noncardioembolic ischemic stroke or high-risk TIA. It is the first approved factor XIa inhibitor, based on the phase 3 OCEANIC-STROKE trial; it is not approved for stroke prevention in atrial fibrillation.
Source:NeurologyLive - Trial
LATE-MT (NEJM): thrombectomy 24–72 hours after anterior-circulation LVO improves function but raises hemorrhage and death
In this randomized trial in China (336 patients; median 38.5 hours to randomization) of patients with imaging-identified salvageable tissue, endovascular therapy gave a better 90-day mRS distribution (common OR 1.74, 95% CI 1.19–2.55). Symptomatic intracranial hemorrhage occurred in 4.8% vs 0%, and 90-day case fatality was 6.0% vs 1.8%.
Source:N Engl J Med (via PubMed) - Meeting
ESMINT welcomes five national societies to its council of affiliated societies
Announced at the ESMINT 2026 congress (Marseille, Sept 2–4): MoUs with five national societies, including Belgium, Portugal and Serbia, bring the council to eight societies.
Source:NeuroNews International - Dissection
RCT: metformin reduces aneurysm wall enhancement in unruptured vertebrobasilar dissecting aneurysms
A randomized controlled trial in JNIS reports that metformin reduced aneurysm wall enhancement on high-resolution vessel wall MRI in unruptured VBDAs (Beijing multicenter group behind the METTLE protocol).
Source:JNIS (via PubMed) - Dissection
STOP-CAD: about 58% of cervical artery dissections fully recanalize by 6 months
Among 1,095 patients with single-vessel CeAD causing stenosis at 63 sites, 57.9% achieved complete recanalization by 6 months. Antithrombotic regimen had no effect, and recurrent stroke was numerically but not significantly higher with incomplete recanalization (5.4% vs 3.5%).
Source:Neurology (via PubMed) - Trial
DART trial: prasugrel monotherapy non-inferior to DAPT after flow diversion for distal aneurysms
In a Brazilian multicenter RCT (n=129) using the coated p48 MW HPC flow diverter, freedom from new deficits at 30 days was 98.5% with prasugrel alone vs 95.2% with DAPT, meeting non-inferiority.
Source:JNIS (via PubMed) - Device
Q'Apel Medical launches Lynx aspiration catheter system in the US
Following FDA clearance, a family of three coaxially compatible aspiration catheters (0.044, 0.058, 0.072 in ID) for stroke thrombectomy was launched in the US.
Source:Endovascular Today - Dissection
Initial MRI/MRA misses most intracranial artery dissections in young stroke: Kyoto multicenter registry
Among 275 stroke patients aged 18–50, 53 had IAD; initial MRI/MRA identified only 17%, while vessel wall MRI (84%) and day-7 follow-up MRA contributed substantially to diagnosis.
Source:European Stroke Journal (via PubMed) - Meeting
WFITN seeks to balance education and innovation ahead of WFITN 2026 Busan (Oct 11–15)
Incoming president Seon-Kyu Lee discusses balancing anatomy/embryology/ethics education with innovation (thrombectomy, flow diversion, AI, robotics), expanding the anatomy course, and a new ethics standards document.
Source:NeuroNews International - Meeting
Open-access journal JNIS Advances debuts at SNIS 23rd Annual Meeting in Seattle
A fully open-access companion to JNIS, edited by Michael Levitt and published by BMJ, launched at SNIS 2026 (Seattle, July 20–24).
Source:SNIS press release - Dissection
The "blister sign" on non-contrast CT detects blood blister-like aneurysms in acute SAH
In 335 patients with non-traumatic SAH across five French centers, the NCCT blister sign had 100% sensitivity and 99.1% specificity for blood blister-like aneurysms.
Source:Neuroradiology (via PubMed) - Dissection
Meta-analysis of flow diversion for blood blister aneurysms (39 studies, 511 patients)
Pooled complete occlusion was 87.6% and good outcome (mRS ≤2) 84.1%, with thromboembolic complications in 6.9% and mortality of 6.6%.
Source:Neurosurgical Review (via PubMed) - Trial
EVIDENCE RCT: flow diversion not superior to coiling ± stenting for unruptured wide-neck aneurysms
In a French 7-center RCT (n=87, mostly ophthalmic aneurysms), composite treatment failure was 18.6% with FD vs 23.3% with coiling ± stenting (not significant).
Source:AJNR (via PubMed) - Device
Perfuze's Millipede88 aspiration catheter receives FDA 510(k) clearance
The MARRS pivotal trial reported 96% deliverability and a 77% first-pass effect in M1 occlusions; a limited US release begins at select stroke centers.
Source:Endovascular Today - Device
Vesalio receives CE mark for NeVa VS (vasospasm) and NeVa 3.0 mm thrombectomy device
NeVa VS for post-aSAH cerebral vasospasm launches in Europe as an alternative to balloon angioplasty; the NeVa 3.0 mm system extends thrombectomy to smaller vessels.
Source:Endovascular Today - Trial
EMBOLISE observation cohort: MMA embolization meets primary effectiveness endpoint in chronic SDH
In patients with smaller hematomas and no motor symptoms, Onyx MMA embolization was superior to observation at 90 days (ISC 2026); stroke and death rates were higher in the treated group.
Source:Medtronic press release - Trial
CHOICE-2: intra-arterial alteplase after successful thrombectomy improves outcomes (ISC 2026)
In a 433-patient Spanish RCT, excellent 90-day outcome was 57.5% vs 42.5%; mortality was numerically higher (12.1% vs 6.4%, not significant).
Source:American Heart Association Newsroom - Trial
Thrombectomy benefits moderate-to-severe medium vessel occlusion stroke in RCT (ISC 2026)
A 537-patient multicenter RCT found that thrombectomy within 24 h improved 90-day outcomes vs medical care alone, without more deaths or symptomatic ICH.
Source:AHA International Stroke Conference 2026 Science News - Dissection
STOP-CAD: dissecting aneurysm in cervical artery dissection not linked to higher stroke risk
Of 4,008 CeAD patients, 13.6% had a dissecting aneurysm at baseline and 7.5% developed one de novo; DA was linked to connective tissue disease and FMD but not to higher ischemic stroke risk through 180 days.
Source:Stroke (via PubMed) - Guideline
2026 AHA/ASA acute ischemic stroke guideline published, with strong recommendation for basilar thrombectomy
Published in Stroke, the guideline strongly recommends EVT for selected basilar artery occlusion patients presenting within 24 h with NIHSS ≥10.
Source:Practical Neurology - Dissection
STOP-CAD: 2-year recurrence of cervical artery dissection ~3.2%; younger age, migraine, FMD predict recurrence
Among 3,836 patients, 2.29% had recurrence (median 53 days), with an estimated 2-year risk of 3.22%; younger age, migraine and fibromuscular dysplasia were independent predictors.
Source:Stroke (via PubMed) - Dissection
Fibromuscular dysplasia and spontaneous cervical artery dissection: STOP-CAD cohort of 3,714 patients
Across 63 sites in 16 countries, FMD was present in 5.3% and was associated with older age, female sex and prior non-cervical dissection; its link to recurrent dissection was also assessed.
Source:JAMA Network Open (via PubMed)